Lysophosphatidate signaling stabilizes Nrf2 and increases the expression of genes involved in drug resistance and oxidative stress responses: implications for cancer treatment.

Lysophosphatidate signaling stabilizes Nrf2 and increases the expression of genes involved in drug resistance and oxidative stress responses: implications for cancer treatment.

Item
http://www.wikidata.org/entity/Q42703615
Recent advances in targeting the autotaxin-lysophosphatidate-lipid phosphate phosphatase axis in vivoG-Protein-Coupled Lysophosphatidic Acid Receptors and Their Regulation of AKT SignalingLipid phosphate phosphatases and their roles in mammalian physiology and pathologyRegulation of autotaxin expression and secretion by lysophosphatidate and sphingosine 1-phosphateThe Bulk of Autotaxin Activity Is Dispensable for Adult Mouse LifeDeterminant role for the gep oncogenes, Gα12/13, in ovarian cancer cell proliferation and xenograft tumor growth.Doxycycline attenuates breast cancer related inflammation by decreasing plasma lysophosphatidate concentrations and inhibiting NF-κB activation.Autotaxin, a lysophospholipase D with pleomorphic effects in oncogenesis and cancer progressionOxidative stress contributes to the tamoxifen-induced killing of breast cancer cells: implications for tamoxifen therapy and resistance.Tetracyclines increase lipid phosphate phosphatase expression on plasma membranes and turnover of plasma lysophosphatidate.Autotaxin Regulates Maintenance of Ovarian Cancer Stem Cells through Lysophosphatidic Acid-Mediated Autocrine Mechanism.Emerging role of NRF2 in chemoresistance by regulating drug-metabolizing enzymes and efflux transporters.Autotaxin inhibitors: a patent review (2012-2016).Autotaxin-Lysophosphatidic Acid: From Inflammation to Cancer Development.Roles of LPA receptor signaling in breast cancer.Coming of Age for Autotaxin and Lysophosphatidate Signaling: Clinical Applications for Preventing, Detecting and Targeting Tumor-Promoting Inflammation.Multi-Target Protective Effects of Gintonin in 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine-Mediated Model of Parkinson's Disease via Lysophosphatidic Acid Receptors.
P2860

Lysophosphatidate signaling stabilizes Nrf2 and increases the expression of genes involved in drug resistance and oxidative stress responses: implications for cancer treatment.

Item
http://www.wikidata.org/entity/Q42703615
description
2014 nî lūn-bûn
@nan
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
2014年论文
@zh
2014年论文
@zh-cn
name
Lysophosphatidate signaling st ...... ications for cancer treatment.
@en
Lysophosphatidate signaling st ...... ications for cancer treatment.
@nl
type
label
Lysophosphatidate signaling st ...... ications for cancer treatment.
@en
Lysophosphatidate signaling st ...... ications for cancer treatment.
@nl
prefLabel
Lysophosphatidate signaling st ...... ications for cancer treatment.
@en
Lysophosphatidate signaling st ...... ications for cancer treatment.
@nl
P1433
P1476
P2093
P304
P31
P356
P407
P433
P478
P50
P577
P698
P356
P1433
P1476
Lysophosphatidate signaling st ...... ications for cancer treatment.
@en
P2093
P304
P31
P356
P407
P433
P478
P50
P577
P698